Here are 29 key notes on orthopedic and spine device companies over the past week.
Amendia acquired Custom Spine's business.
Amedica also signed an original equipment manufacturer letter of intent supply agreement with an orthopedic device design and manufacturing company.
Bacterin purchased outstanding common stock of X-spine Systems to create a new company, Xtant Medical.
BioStructures' Signafuse Bioactive Bone Graft Putty has been used in 4,000 implantations.
Second quarter net sales dropped 1 percent for DJO Global.
EOS imaging, a Paris-based company focused on two-dimensional and three-dimensional orthopedic medical imaging equipment, appointed a new board member chairman, Gerard Hascoet.
Exactech reported $3.7 million in net income for the second quarter of 2015.
Histogenics appointed Stephen Kennedy as chief technology officer, effective immediately.
During the first six months of 2015, Implanet spine sales were up 66 percent over the same period last year.
Integra LifeSciences reported a second quarter revenue increase and full-year guidance after the SeaSpine spin-off completes — Revenue increased 5.5 percent over the same period last year to $244.1 million.
Intuitive Surgical appointed Michael A. Friedman, MD, to its board of directors.
ISTO Technologies recently received a Small Business Innovation Research grant from the National Institutes of Health.
Mazor Robotics reported a net loss at $7.3 million for the six months end along with second quarter financials.
Materialise entered into an agreement with Lima Corporate that allows Lima to offer the Materialise-powered surgical knee guide system in the European Economic Area and Switzerland.
Materialise signed a partnership agreement with Japan Medical Dynamic Marketing for its total hip replacement guide system.
Omar Ishrak's, Medtronic's CEO, compensation increased 79.8 percent this year.
Nevro announced that the results of the SENZA-RCT study showed that the SENZA system was found to be safe and also had a substantial positive impact on leg and back pain sufferers.
NuVasive shares jumped 10 percent on July 29.
NuVasive's revenue increased 6.4 percent to $202.9 million for the second quarter of 2015.
NuVasive also confirmed it reached a settlement with the United States' Department of Justice in regards to the subpoena issued to the company by the Office of Inspector General of HHS in 2013 — the company will pay $13.5 million.
SeaSpine released preliminary financial results for the company's first quarter as a separate entity from Integra LifeSciences, and its total revenue for the second quarter is expected to hit $33.5 million.
SeaSpine named Tyler Lipschultz vice president, orthobiologics and business development; and named Laetitia Cousin vice president, regulatory, clinical and quality assurance.
Smith & Nephew, a London-based company, chose Fort Worth for its headquarters for the Advanced Wound Management division.
Smith & Nephew appointed Robin Freestone to its board as non-executive director and member of the audit committee.
Smith & Nephew also reported a 5 percent increase in second quarter revenue over the same period last year to $1.16 billion.
Carl Lauryssen, MD, a spine surgeon with NeuroTexas, will be co-principal investigator of the study for Spinal Kinetics' M6-C Artificial spinal disc at Lakeway Regional Medical Center.
Spine Pain Management has received a final patent allowing all claims for its Quad Video HALO.
Stryker Director Ronda E. Stryker sold 12,000 shares.
Leerink Swann analysts reaffirmed Stryker stock's "outperform" rating.
More articles on devices:
EOS imaging names new board chairman: 5 key notes
BRIC spinal surgery market outlook to 2020: five things to know
Integra LifeSciences Q2 revenue up 5.5%: 7 things to know